Immunogenicity, safety, and reactogenicity of a half- versus full-dose BNT162b2 (Pfizer-BioNTech) booster following a two-dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac priming schedule in Mongolia: a randomised, controlled, non-inferiority trial.

Autor: Batmunkh T; National Centre for Communicable Diseases, Ulaanbaatar, Mongolia., Moore KA; Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Australia., Thomson H; Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Australia., Altangerel B; Onoshmed Laboratory, Sukhbaatar District, Ulaanbaatar, Mongolia., Amraa O; National Centre for Communicable Diseases, Ulaanbaatar, Mongolia., Avaa N; Onoshmed Laboratory, Sukhbaatar District, Ulaanbaatar, Mongolia., Batbayar L; Sukhbaatar District Health Centre, Sukhbaatar District, Ulaanbaatar, Mongolia., Batsukh K; General Laboratory of Clinical Pathology, First Central Hospital of Mongolia, Ulaanbaatar, Mongolia., Bright K; Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Australia., Burentogtokh T; General Laboratory of Clinical Pathology, First Central Hospital of Mongolia, Ulaanbaatar, Mongolia., Ha Do LA; Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Australia., Dorj G; Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia., Hart JD; Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Australia., Javkhlantugs K; Bayangol District Health Centre, Bayangol District, Ulaanbaatar, Mongolia., Jigjidsuren S; General Laboratory of Clinical Pathology, First Central Hospital of Mongolia, Ulaanbaatar, Mongolia., Justice F; Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Australia., Li S; Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Australia., Licciardi PV; Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Australia., Mashbaatar K; National Centre for Communicable Diseases, Ulaanbaatar, Mongolia., Mazarakis N; Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Australia., Neal EFG; Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Australia., Nguyen CD; Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Australia., Ochirbat B; Mongolia Ministry of Health, Sukhbaatar District, Ulaanbaatar, Mongolia., Tsolmon B; National Centre for Communicable Diseases, Ulaanbaatar, Mongolia.; Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia., Tuya A; Onoshmed Laboratory, Sukhbaatar District, Ulaanbaatar, Mongolia., Surenjav U; National Centre for Public Health, Ulaanbaatar, Mongolia., von Mollendorf C; Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Australia., Mulholland K; Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Australia.

Publikováno v: The Lancet regional health. Western Pacific [Lancet Reg Health West Pac] 2023 Nov 21; Vol. 42, pp. 100953. Date of Electronic Publication: 2023 Nov 21 (Print Publication: 2024).